ADVOCATE. CONNECT. INNOVATE.

Category Archives: Other

Tackling Emerging Viruses: CLSA Q&A with PaxVax CEO Nima Farzan

In recent years, a new round of terrifying viruses has captured the public’s imagination. Ebola, H1N1, SARS, Zika and other pathogens strike rapidly, mutate without warning and pose a major threat to public health. We recently chatted with PaxVax CEO Nima Farzan about how we can better unite government and industry to prepare for these dangers.

A Biotech’s Treatment Changes the Game

Last week, CLSA Member Vertex Pharmaceuticals received FDA approval to treat Cystic Fibrosis. The approval is a shift away from prevoius CF treatments, and it addresses the underlying cause of the disease according to our partners at Biotech Primer. In their weekly email to subscribers, Biotech Primer said Vertex shifted the paradigm of treating cystic fibrosis (CF) … Continue reading A Biotech’s Treatment Changes the Game

Biosimilars, Outsourcing Impact Biopharma Manufacturing Production

The 12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production from BioPlan Associates, Inc., provides global analysis of biopharma trends, based on input from 237 biomanufacturers and 164 suppliers in 28 countries. The 12th Annual Report and survey is the industry’s definitive, quantitative analysis and includes 12 years of biopharma trends analysis and … Continue reading Biosimilars, Outsourcing Impact Biopharma Manufacturing Production